Anthony H Nguyen

Array ( [id] => 1320456 [patent_doc_number] => 06605713 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-12 [patent_title] => 'Mirror-symmetrical selection and evolution of nucleic acids' [patent_app_type] => B1 [patent_app_number] => 09/254126 [patent_app_country] => US [patent_app_date] => 1999-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 29 [patent_no_of_words] => 14199 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605713.pdf [firstpage_image] =>[orig_patent_app_number] => 09254126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4386541 [patent_doc_number] => 06262248 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'RPS gene family, primers, probes, and detection methods' [patent_app_type] => 1 [patent_app_number] => 9/301085 [patent_app_country] => US [patent_app_date] => 1999-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 36 [patent_no_of_words] => 37462 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262248.pdf [firstpage_image] =>[orig_patent_app_number] => 301085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4179836 [patent_doc_number] => 06037357 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'N-benzoyl-.alpha.-alkylated azatyrosines as anticancer agents' [patent_app_type] => 1 [patent_app_number] => 9/296445 [patent_app_country] => US [patent_app_date] => 1999-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6202 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037357.pdf [firstpage_image] =>[orig_patent_app_number] => 296445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6839178 [patent_doc_number] => 20030036518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'ARTIFICIAL POLYMERIC MEMBRANE STRUCTURE, METHOD FOR PREPARING SAME, METHOD FOR PREPARING THIS POLYMER, PARTICLE AND FILM CONTAINING THIS STRUCTURE' [patent_app_type] => new [patent_app_number] => 09/284754 [patent_app_country] => US [patent_app_date] => 1999-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13904 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036518.pdf [firstpage_image] =>[orig_patent_app_number] => 09284754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356102 [patent_doc_number] => 06200960 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Inhibition of proliferation of cells' [patent_app_type] => 1 [patent_app_number] => 9/142779 [patent_app_country] => US [patent_app_date] => 1999-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6559 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200960.pdf [firstpage_image] =>[orig_patent_app_number] => 142779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4117546 [patent_doc_number] => 06046321 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Antisense modulation of G-alpha-i1 expression' [patent_app_type] => 1 [patent_app_number] => 9/289377 [patent_app_country] => US [patent_app_date] => 1999-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25149 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/046/06046321.pdf [firstpage_image] =>[orig_patent_app_number] => 289377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4201163 [patent_doc_number] => 06013788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Antisense modulation of Smad3 expression' [patent_app_type] => 1 [patent_app_number] => 9/289376 [patent_app_country] => US [patent_app_date] => 1999-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25547 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013788.pdf [firstpage_image] =>[orig_patent_app_number] => 289376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4379198 [patent_doc_number] => 06277574 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Genes associated with diseases of the kidney' [patent_app_type] => 1 [patent_app_number] => 9/289349 [patent_app_country] => US [patent_app_date] => 1999-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13161 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277574.pdf [firstpage_image] =>[orig_patent_app_number] => 289349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4153593 [patent_doc_number] => 06124272 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Antisense modulation of PDK-1 expression' [patent_app_type] => 1 [patent_app_number] => 9/289466 [patent_app_country] => US [patent_app_date] => 1999-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29002 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124272.pdf [firstpage_image] =>[orig_patent_app_number] => 289466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4117533 [patent_doc_number] => 06046320 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Antisense modulation of MDMX expression' [patent_app_type] => 1 [patent_app_number] => 9/289267 [patent_app_country] => US [patent_app_date] => 1999-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31090 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/046/06046320.pdf [firstpage_image] =>[orig_patent_app_number] => 289267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342336 [patent_doc_number] => 06586396 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Subcutaneous administration of natriuretic peptide' [patent_app_type] => B1 [patent_app_number] => 09/287892 [patent_app_country] => US [patent_app_date] => 1999-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11423 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586396.pdf [firstpage_image] =>[orig_patent_app_number] => 09287892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4168154 [patent_doc_number] => 06140124 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Antisense modulation of P38 mitogen activated protein kinase expression' [patent_app_type] => 1 [patent_app_number] => 9/286904 [patent_app_country] => US [patent_app_date] => 1999-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23896 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140124.pdf [firstpage_image] =>[orig_patent_app_number] => 286904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6887778 [patent_doc_number] => 20010008772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-19 [patent_title] => 'CATIONIC LIPID FORMULATION DELIVERING NUCLEIC ACID TO PERITONEAL TUMORS' [patent_app_type] => new-utility [patent_app_number] => 09/283543 [patent_app_country] => US [patent_app_date] => 1999-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13350 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20010008772.pdf [firstpage_image] =>[orig_patent_app_number] => 09283543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260308 [patent_doc_number] => 06204253 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Factors which interact with oncoproteins' [patent_app_type] => 1 [patent_app_number] => 9/269617 [patent_app_country] => US [patent_app_date] => 1999-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4403 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204253.pdf [firstpage_image] =>[orig_patent_app_number] => 269617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284011 [patent_doc_number] => 06210892 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Alteration of cellular behavior by antisense modulation of mRNA processing' [patent_app_type] => 1 [patent_app_number] => 9/277020 [patent_app_country] => US [patent_app_date] => 1999-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24698 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/210/06210892.pdf [firstpage_image] =>[orig_patent_app_number] => 277020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4213761 [patent_doc_number] => 06110740 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Human vault RNA' [patent_app_type] => 1 [patent_app_number] => 9/276975 [patent_app_country] => US [patent_app_date] => 1999-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5794 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/110/06110740.pdf [firstpage_image] =>[orig_patent_app_number] => 276975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4295839 [patent_doc_number] => 06184212 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Antisense modulation of human mdm2 expression' [patent_app_type] => 1 [patent_app_number] => 9/280805 [patent_app_country] => US [patent_app_date] => 1999-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17833 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/184/06184212.pdf [firstpage_image] =>[orig_patent_app_number] => 280805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1163091 [patent_doc_number] => 06756054 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-29 [patent_title] => 'Polycationic sterol derivatives as transfection agents' [patent_app_type] => B1 [patent_app_number] => 09/194267 [patent_app_country] => US [patent_app_date] => 1999-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 29 [patent_no_of_words] => 10226 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/756/06756054.pdf [firstpage_image] =>[orig_patent_app_number] => 09194267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4201076 [patent_doc_number] => 06013783 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Boronic acid containing oligonucleotides and polynucleotides' [patent_app_type] => 1 [patent_app_number] => 9/272834 [patent_app_country] => US [patent_app_date] => 1999-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16470 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013783.pdf [firstpage_image] =>[orig_patent_app_number] => 272834 [rel_patent_id] =>[rel_patent_doc_number] =>)